After-Hours Update: OREX, ORCL, GOOG
Thursday, July 29, 2021 8:31 PM

Related Stories



Orexigen Therapeutics, Inc. (NASDAQ: OREX) said late Thursday that results from a company-sponsored study showed that patients taking obesity drug Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo. Shares of the biopharmaceutical firm soared more than 15% in after hours trading.

The US Justice Department said late Thursday that it has filed a lawsuit against US business software giant Oracle NASDAQ: ORCL), accusing it of overcharging on a government software contract that ran from 1998 to 2006.

Shares of Google Inc. (NASDAQ: GOOG) fell nearly 1% in after-hours trading after the company said that its internet search engine and advertising platform in China were fully blocked on Thursday.

Disclosure: Author doesn't own any of the stocks discussed here.


 

Sponsors

Symbol :

Advertisement

Market news:

More news


Advertisement

    Recent Estimates

AnalystFirm NameSymbolEPS Estimate
XXXXXXXXXX HOGS$0.35
XXXXXXXXXX AGNC$1.16
XXXXXXXXXX LVS$0.08
XXXXXXXXXX SNDK$0.87
XXXXXXXXXX APKT$0.13
XXXXXXXXXX CRUS$0.26
XXXXXXXXXX LCC$1.18
XXXXXXXXXX BAC$0.24
robertbig j JPM$0.71
XXXXXXXXXX GOOG$5.78